PRIMARY BILIARY CHOLANGITIS (PBC)
Clinical trials for PRIMARY BILIARY CHOLANGITIS (PBC) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS (PBC) trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS (PBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for rare liver disease
Disease control CompletedThis small pilot study tested whether adding fenofibrate to standard treatment helps people newly diagnosed with primary biliary cholangitis, a rare autoimmune liver disease. The study involved 30 participants who were randomly assigned to receive either the combination treatment…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: EARLY_PHASE1 • Sponsor: Han Ying • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First humans dosed in early trial for rare liver disease
Knowledge-focused CompletedThis was the first study in humans for an experimental drug called PVT201. The main goal was to check its initial safety and see how the body processes it. Researchers gave single, increasing doses to 24 healthy volunteers and a small group of patients with primary biliary cholan…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: PHASE1 • Sponsor: Parvus Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC